Global Artificial Organs Research Report 2019: Immunosuppressants Hold Promise in the Market - ResearchAndMarkets.com

DUBLIN--()--The "Artificial Organs: Global Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

This report provides separate comprehensive analytics for the US, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The report analyzes the worldwide markets for Artificial Organs in US$ Million by the following Product Segments:

  • Artificial Heart
  • Artificial Kidneys
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs

The report profiles 42 companies including many key and niche players such as:

  • ABBOTT (USA)
  • Abiomed, Inc. (USA)
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • Baxter International, Inc. (USA)
  • F.Hoffmann-La Roche Ltd. (Switzerland)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Jarvik Heart, Inc. (USA)
  • Medtronic, Inc. (USA)
  • HeartWare International, Inc. (USA)
  • Nikkiso Co., Ltd. (Japan)
  • Nipro Corporation (Japan)
  • SynCardia Systems, LLC (USA)
  • Toray Medical Co., Ltd. (Japan)
  • Xenios AG (Germany)

Key Topics Covered:

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

2. INDUSTRY OVERVIEW

Artificial Organs Revolutionize Medical Industry

Growth Drivers

Growth Inhibitors

Artificial Organs Poised to Witness Significant Demand

The United States - A Dominant Force in the Artificial Organs Market

Artificial Kidneys Garner a Larger Pie in the Artificial Organs Market

Demand and Supply Imbalance

Competitive Scenario

Technological Advancements Spearheading Growth

3. ANALYSIS BY SEGMENT

Artificial Heart

Medical Community Poised to Embrace Artificial Heart

Ventricular Assist Devices

Select Ventricular Assist Devices

Artificial Mechanical Heart Valves Come of Age

Artificial Kidney

Kidney Failure: A Major Concern

Artificial Kidney or Dialyzers Market

Major Initiatives in the Artificial Kidney Space

The Kidney Project

Current Status of the Kidney Project

Artificial Kidney Likely to Begin Human Trials by 2019

Wearable Artificial Kidney May be Boon to Dialysis Patients

Artificial Liver

Bioartificial Liver Innovation Shows Potential to Avoid Transplants

Types of Liver Support Devices

Artificial Pancreas

Artificial Pancreas Device System Market Presents Lucrative Opportunities

Market Overview

Scientific Community Inches towards Artificial Pancreas System

Competition and Key Developments in Artificial Pancreas Space

Bionic Pancreas System

Types of Artificial Pancreas Delivery Systems and FDA's Efforts for their Development

Researchers Develop Improvised Artificial Lungs Prototype with Vasculature

Crucial Artificial Lung Trial Enrolls Record Number of Patients

Lightweight and Portable Artificial Lung Innovations

4. MARKET TRENDS AND ISSUES

Increasing Incidence of Cardiovascular Disease Drive the Market for Artificial Heart and VAD

Higher Development Costs and Lengthy Regulatory Process - Stumbling Blocks for Product Commercialization

Lack of Requisite Expertise - Hindering Implantation Process

Xenotransplantation - Other Alternative to Donor Organ Shortage

Artificial Organs from Cloned Animal Cells - A Promising Trend

Immunosuppressants Hold Promise in Artificial Organs Market

Move towards Smaller Implantable Devices

Barriers to Entry Significantly High in Dialyzers Market

Reuse of Dialyzers - A Major Issue in Dialysis Industry

Poor Reimbursement Environment Stymies Innovation

Product Recalls - A Major Blow to the Manufacturers

Higher Cost of Artificial Organs Hampers Broader Adoption

Major Issues Related to Artificial Organs

Financial

Legal

Ethical

Social

5. MACRO FACTORS IMPACTING THE ARTIFICIAL ORGANS MARKET

Aging Population: A Strong Growth Driver

Global Aging Population Statistics - Opportunity Indicators

Dialysis Market to Stage Steady Growth Amid Rising Prevalence of Kidney Diseases

Distribution of Dialysis Patients by Modality

Developed Markets Maintain Lead, Emerging Markets to Dictate Momentum

Rising Incidence of Diabetes: Opportunity Indicator for Artificial Pancreas

Growing Number of Type 1 Diabetes Cases in Children

6. 3D BIOPRINTING - A GAME CHANGER FOR THE ARTIFICIAL ORGANS INDUSTRY

Application of 3D-Printing in the Medical Field

3D Printing Revolutionizing the Medical Industry's Artificial Organ Development Segment

Soft 3D Bioprinting Eliminates Concerns of Hard Plastic-based Organ Models

3D Printed Organ Models with Sensors Enable Real-time Feedback

7. TECHNOLOGICAL ADVANCEMENTS

UCLA Researchers Develop Cancer-Fighting Cells

Production of 3D-like Artificial Organs in a Device that Works like a Cotton Candy Machine

Harvard Scientists Create Tissue Containing Blood Vessels

University of Washington Researchers Create Communicating Yeast Cells

Scientists Define Morphospace to Evaluate Viability of Artificial Organs

8. PRODUCT OVERVIEW

Artificial Organs

Categorization of Artificial Organs

External Artificial Organs

Internal or Implantable Artificial Devices

Artificial Heart

Total Artificial Heart (TAH)

Ventricle Assist Device (VAD)

Table 20: Distribution of Various Uses of VADs (includes corresponding Graph/Chart)

Right Ventricular Assist Systems (RVAS)

Left Ventricular Assist Systems (LVAS)

Categorization of LVAS

First Generation LVAS

Second Generation LVAS

Third Generation LVAS

Benefits of LVAS

Major Limitations and Complications of VADs

Infection

Internal Bleeding

Thrombus

Dependability

Cost

Natural Human Heart

Heart Diseases

Congenital Heart Disease

Congestive Heart Failure

Types of Heart Failure

Diastolic Heart Failure

Systolic Heart Failure

Artificial Heart - A Historical Perspective

Major Milestones in Artificial Heart Development

Jarvik-7

AbioCor Total Artificial Heart

CardioWest Temporary Total Artificial Heart

DuraHeart LVAS

HeartSaverVAD

VentrAssist Left Ventricular Assist Device

Artificial Kidney (Dialyzer)

Limitations of Artificial Kidney

Types of Dialysis

Hemodialysis

Peritoneal Dialysis

Advancements in Artificial Kidney Technology

Bioartificial Kidneys

Limitations of Bioartificial Kidneys

Hindrances to Develop Implantable Artificial Kidney

Artificial Kidneys - A Historical Perspective

Artificial Liver

Overdose of Drugs - A Leading Cause for Liver Damage

Categorization of Liver Devices

Mechanical Systems

Liver Dialysis Unit

Bio-Artificial Systems

Capillary Hollow Fiber Systems

Direct Perfusion Systems

Entrapment Based Systems

Major BAL Devices

Extracorporeal Liver Assist Device (ELAD)

Cellular Components

Types of Bioreactor

Hybrid Artificial Liver Support System

History of Artificial Liver

Liver Assist Devices - Major Milestones

Nonbiological Method Introduction Time Line

Biological Method Introduction Time Line

Artificial Pancreas

Insulin Pumps - Historical Perspective

Bioartificial Pancreas

Nanotechnology in Artificial Pancreas

Artificial Lungs (Oxygenator)

About Human Lungs

Types of Artificial Lung

Intravenous Membrane Oxygenator

Hattler Respiratory Catheter

MC3 Pulmonary Assist Device

In-Series

In-Parallel

BioLung

Heart-Lung Bypass Machine

Role of Artificial Lungs during Surgery

Direct Contact Device

Indirect-Contact Type-Membrane Devices

Biorubber to be used in Artificial Lungs

History of Artificial Lungs

An Overview of Tissue Engineering

9. REGULATORY ENVIRONMENT

Regulatory Environment in the US

Regulatory Environment in Europe

10. COMPETITIVE LANDSCAPE

10.1 Focus on Select Global Players

10.2 Recent Industry Activity

Vital Therapies Reports the Failure of ELAD System in Phase III Trial

A Ten-Year-Old Becomes the Youngest Patient to Receive 50CC Temporary TAH

Tandem Diabetes Care Secures FDA Approval for Closed-loop Insulin System

ALung Registers Record Enrollment for the Pivotal Trial of Artificial Lung Technology

Automated Insulin Delivery and Monitoring System Receives FDA Approval for Use in Younger Pediatric Patients

Artificial Lung Rises Hope for Future Transplant Patients

Medtronic Introduces Artificial Pancreas' Hybrid Closed Loop System in the U.S.

Johnson & Johnson Exits Insulin Pump Business

B. Braun Introduces New Dialyzer

Versa Ventures Acquires Syncardia

Medtronic and HeartWare International Ink Merger Agreement

Vivonics Sells Artificial Lung Technology to Lung Biotechnology PBC

Insulet Corporation Enters into a Partnership and License Agreement with Mode AGC

Cellnovo Group Enters into a Partnership with TypeZero

Medtronic Launches MiniMed(TM) 640G System

Pandorum Develops Artificial Human Liver Tissue

11. GLOBAL MARKET PERSPECTIVE

12. REGIONAL MARKET PERSPECTIVE

13. COMPANY PROFILES

Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47)

  • The United States (20)
  • Japan (8)
  • Europe (13)
    • France (2)
    • Germany (4)
    • The United Kingdom (2)
    • Rest of Europe (5)
  • Asia-Pacific (Excluding Japan) (4)
  • Middle East (2)

For more information about this report visit https://www.researchandmarkets.com/r/mfwvyj

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900